An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects

Neuropsychobiology

Volumn 41, Issue 1, 2000, Pages 48-53

  Benjamin, Jonathan ^a   Osher, Yamima ^a   Lichtenberg, Pesach ^b   Bachner Melman, Rachel ^b   Gritsenko, Inga ^b   Kotler, Moshe ^a   Belmaker, Robert H ^a   Valsky, Vadim ^b   Drendel, Michael ^b   Ebstein, Richard P ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HERZOG HOSPITAL   (Israel)

Author keywords

Catechol O methyltransferase; Genes; Persistence; Personality; Polymorphism; Serotonin transporter promoter region; Tridimensional Personality Questionnaire

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; SEROTONIN TRANSPORTER; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; CONFERENCE PAPER; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; MALE; NEUROSIS; NORMAL HUMAN; PERSONALITY; PRIORITY JOURNAL; PROMOTER REGION; QUESTIONNAIRE; REWARD; SIBLING; STATISTICAL ANALYSIS;

EID: 0033964986     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026632     Document Type: Conference Paper

References (46)

1. Cloninger CR: A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987;44:573-588.
2. Bergeman CS, Chipuer HM, Plomin R, Pedersen NL, McClearn GE, Nesselroade JR, Costa PT Jr, McCrae RR: Genetic and environmental effects on openness to experience, agreeableness, and conscientiousness: An adoption/twin study. J Pers 1993;61:159-179.
3. Heath AC, Cloninger CR, Martin NG: Testing a model for the genetic structure of personality: A comparison of the personality systems of Cloninger and Eysenck. J Pers Soc Psychol 1994;66:762-775.
4. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH: Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet 1996;12:81-84.
5. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 1996;12:78-80.
6. Boulton AA, Eisenhofer G: Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview. Adv Pharmacol 1998;42:273-292.
7. Mannisto PT: Catechol O-methyltransferase: Characterization of the protein, its gene, and the preclinical pharmacology of COMT inhibitors. Adv Pharmacol 1998;42:324-328.
8. Weinshilboum R, Dunnette J: Thermal stability and the biochemical genetics of erythrocyte catechol-O-methyl-transferase and plasma dopamine-beta-hydroxylase. Clin Genet 1981;19: 426-437.
9. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243-250.
10. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M: CatecholO-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998;95:9991-9996.
11. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA: Genotype determining low catechol-O-methyltrans-ferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sei USA 1997;94:4572-4575.
12. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE: Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol Psychiatry 1998;43:425-431.
13. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA: Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder (in process citation). Biol Psychiatry 1999;45:1178-1189.
14. Kotler M, Peretz B, Cohen H, Averbuch AV, Grinshpoon A, Gritsenko I, Nemanov L, Ebstein RP: Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet (Neuropsychiatr Genet), in press.
15. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J: Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 1998;155:835-837.
16. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM: Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: Evidence for association with aggressive and antisocial behavior. Psychiatry Res 1997;69:71-77.
17. Eisenberg J, Zohar A. Mei-Tal G, Steinberg A, Tartakovsky E, Gritsenko I, Nemanov L, Ebstein RP: A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Gen (Neuropsychiatr Genet), in press.
18. Vandenbergh DJ, Rodriguez LA, Miller IT, UhI GR, Lachman HM: High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 1997;74:439-442.
19. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP: Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.
20. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region (see comments). Science 1996;274:1527-1531.
21. Cloninger CR, Svrakic DM, Przybeck TR: A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975-990.
22. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH: No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 1997; 2:224-226.
23. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky A, Gritsenko I, Nemanov L, Ebstein RP: A haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet (Neuropsychiatr Genet), in press.
24. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK: Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 1999;88:61-66.
25. Kidd KK, Morar B, Castiglione CM, Zhao H, Pakstis AJ, Speed WC, Bonne-Tamir B, Lu RB, Goldman D, Lee C, Nam YS, Grandy DK, Jenkins T, Kidd JR: A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet 1998;103:211-227.
26. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF: Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996;67:468-472.
27. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz JC, Sokoloff P: Meta-analysis of DRD3 gene and schizophrenia: Ethnic heterogeneity and significant association in Caucasians. Am J Med Genet 1998;81:318-322.
28. Williams J, McGuffin P, Nothen M, Owen MJ: Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia (letter). Lancet 1997;349:1221.
29. Duaux E, Gorwood P, Griffon N, Bourdel MC, Sautel F, Sokoloff P, Schwartz JC, Ades J, Loo H, Poirier MF: Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence (in process citation). Mol Psychiatry 1998;3:333-336.
30. Reenila I, Tuomainen P, Soinila S, Mannisto PT: Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin. Neurosci Lett 1997;230:155-158.
31. Hong J, Shu-Leong H,Tao X, Lap-Ping Y: Distribution of catechol-O-methyltransferase expression in human central nervous system (in process citation). Neuroreport 1998;9:2861-2864.
32. Karhunen T, Tilgmann C, Ulmanen I, Panula P: Catechol-O-methyltransferase (COMT) in rat brain: Immunoelectron microscopic study with an antiserum against rat recombinant COMT protein. Neurosci Lett 1995;187:57-60.
33. Karhunen T, Tilgmann C, Ulmanen I, Panula P: Neuronal and non-neuronal catechol-O-methyltransferase in primary cultures of rat brain cells. Int J Dev Neurosci 1995;13:825-834.
34. Karhunen T, Ulmanen I, Panula P: Catechol-O-methyltransferase in rat sensory ganglia and spinal cord. Neuroscience 1996;73:267-276.
35. Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF: Neuroticism is not associated with the serotonin promoter (5-HTTLPR) polymorphism. Mol Psychiatry 1999;4:93-96.
36. Gelernter J, Kranzler H, Coccaro EF, Siever LJ, New AS: Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry 1998;155:1332-1338.
37. Gustavsson JP, Nothen MM, Jonsson EG, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Sedvall GC, Propping P, Asberg M: No association between serotonin transporter gene polymorphisms and personality traits. Neuropsychiatr Genet, submitted.
38. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, Tan X, Easteal S: An association study of a functional polymorphism of the serotonin transporter with personality and psychiatric symptoms. Mol Psychiatry 1998;3:449-451.
39. Benjamin JYO, Kotler M, Gritsenko I, Nemanov L, Belmaker RH, Ebstein RP: TPQ personality trait of novelty seeking associated with the dopamine receptor D4 exon III (DRD4). serotonin transporter promoter region (5-HTTLPR) and catcchol O-methyltransferase (COMT val-met) polymorphisms. Mol Psychiatry, in press.
40. Auerbach J, Geller V, Letzer S, Shinwell R, Belmaker RH, Levine J. Ebstein RP: Dopamine D4 receptor (D4DR) and scrotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in two month old infants. Mol Psychiatry 1999;4:369-373.
41. Ebstein RP, Levine J, Geller V, Auerbach J, Gritsenko I, Belmaker RH: Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Mol Psychiatry 1998;3:238-246.
42. Ebstein RP, Segman R, Benjamin J, Osher Y, Nemanov L, Belmaker RH: 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: Interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet 1997;74:65-72.
43. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C, MacMurray JP, Dietz G, Muhleman D: Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am J Med Genet 1996;67:264-288.
44. Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang X, Belin TR, Sparkes RS: D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet 1998:81:257-267.
45. Kuhn KU, Meyer K, Nothen MM, Gansicke M. Papassotiropoulos A, Maier W: Allelic variants of dopaminc receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: Replication tests. Am J Med Genet 1999;88:168-172.
46. Cloninger CR, Van Eerdewegh P, Goate A, Edenberg HJ, Blangero J, Hesselbrock V, Reich T, Nurnberger J Jr, Schuckit M, Porjesz B, Crowe R, Rice JP, Foroud T, Przybeck TR, Almasy L, Bucholz K, Wu W, Shears S, Carr K, Crose C, Willig C, Zhao J, Tischfield JA, Li TK, Conneally PM: Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet 1998:81:313-317.